Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodore Steiner

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Molecular Biomedicine|December 12, 2022
Inhibition of glycogen synthase kinase-3-beta (GSK3β) blocks nucleocapsid phosphorylation and SARS-CoV-2 replicationTirosh Shapira, Selvarani Vimalanathan, Celine Rens, et al.
JAMA|January 13, 2016
Frozen vs Fresh Fecal Microbiota Transplantation and Clinical Resolution of Diarrhea in Patients With Recurrent Clostridium difficile Infection: A Randomized Clinical TrialChristine H Lee, Theodore Steiner, Elaine O Petrof, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 30, 2015
Longitudinal clinical findings and outcome among patients with Cryptococcus gattii infection in British ColumbiaPeter Phillips, Eleni Galanis, Laura MacDougall, et al.
Plos One|March 22, 2019
Whole blood human transcriptome and virome analysis of ME/CFS patients experiencing post-exertional malaise following cardiopulmonary exercise testingJerome Bouquet, Tony Li, Jennifer L Gardy, et al.
Scientific Reports|April 18, 2024
Adaptive immune responses to two-dose COVID-19 vaccine series in healthy Canadian adults ≥ 50 years: a prospective, observational cohort studyGabrielle N Gaultier, Brynn McMillan, Chad Poloni, et al.
Biorxiv : the Preprint Server for Biology|May 11, 2021
A novel highly potent inhibitor of TMPRSS2-like proteases blocks SARS-CoV-2 variants of concern and is broadly protective against infection and mortality in miceTirosh Shapira, I Abrrey Monreal, Sébastien P Dion, et al.
The Lancet. Infectious Diseases|September 18, 2020
Safety, immunogenicity, and efficacy of a Clostridioides difficile toxoid vaccine candidate: a phase 3 multicentre, observer-blind, randomised, controlled trialGuy de Bruyn, David L Gordon, Theodore Steiner, et al.
Nature|March 28, 2022
A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeuticTirosh Shapira, I Abrrey Monreal, Sébastien P Dion, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Molecular Biomedicine|December 12, 2022
Inhibition of glycogen synthase kinase-3-beta (GSK3β) blocks nucleocapsid phosphorylation and SARS-CoV-2 replicationTirosh Shapira, Selvarani Vimalanathan, Celine Rens, et al.
JAMA|January 13, 2016
Frozen vs Fresh Fecal Microbiota Transplantation and Clinical Resolution of Diarrhea in Patients With Recurrent Clostridium difficile Infection: A Randomized Clinical TrialChristine H Lee, Theodore Steiner, Elaine O Petrof, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 30, 2015
Longitudinal clinical findings and outcome among patients with Cryptococcus gattii infection in British ColumbiaPeter Phillips, Eleni Galanis, Laura MacDougall, et al.
Plos One|March 22, 2019
Whole blood human transcriptome and virome analysis of ME/CFS patients experiencing post-exertional malaise following cardiopulmonary exercise testingJerome Bouquet, Tony Li, Jennifer L Gardy, et al.
Scientific Reports|April 18, 2024
Adaptive immune responses to two-dose COVID-19 vaccine series in healthy Canadian adults ≥ 50 years: a prospective, observational cohort studyGabrielle N Gaultier, Brynn McMillan, Chad Poloni, et al.
Biorxiv : the Preprint Server for Biology|May 11, 2021
A novel highly potent inhibitor of TMPRSS2-like proteases blocks SARS-CoV-2 variants of concern and is broadly protective against infection and mortality in miceTirosh Shapira, I Abrrey Monreal, Sébastien P Dion, et al.
The Lancet. Infectious Diseases|September 18, 2020
Safety, immunogenicity, and efficacy of a Clostridioides difficile toxoid vaccine candidate: a phase 3 multicentre, observer-blind, randomised, controlled trialGuy de Bruyn, David L Gordon, Theodore Steiner, et al.
Nature|March 28, 2022
A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeuticTirosh Shapira, I Abrrey Monreal, Sébastien P Dion, et al.
Pageof 2